On January 19th of this year, Algernon Pharmaceuticals (CSE: AGN) hit a high of $11.90 per share and closed at $11.15 per share. On that same day, the largest publicly traded chronic cough focused companies BELLUS Health (BLU) closed at $6.05 per share and Trevi Therapeutics (TRVI) closed at $0.6987 per share.
Since January 19th, BLU has gained by 86.28% to a closing price yesterday of $11.27 per share with a market cap of US$1.418 billion!
Since January 19th, TRVI has gained by 382.32% to a closing price yesterday of $3.37 per share with a market cap of US$144.13 million!
AGN's market cap at yesterday's closing price of $5.15 per share is only US$9.325 million!
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA has received compensation from AGN of US$100,000 cash for a twelve-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.
Preparing Americans for Hyperinflation
